SARS-CoV-2 antigen test kit is based on specific antibody-antigen reaction and immunoassay technique to qualitatively detect the COVID-19 antigen in clinical specimen with rapid and accurate results. Samples must be collected by healthcare professionals.
[Product Features]
• Non-invasive
• Simple to use
• Convenient, no devices required
• Rapid, get a result in 15 minutes
• Stable, with high accuracy
• Inexpensive, cost-efficiency
[Packing Size] 1 test/kit, 5 tests/kit, 25 tests/kit
This test is intended for use in individuals with symptoms or other epidemiological reasons to suspect a COVID-19 infection.
[Product Features]
• No prescription needed, nasal swabs can be collected by individuals at home
• Rapid, deliver results in 15 minutes
• Safe, authenticity verification available
• Stable, with high accuracy
• Card design, easy to use and cost-effective
[Packing Size] 1 test/kit, 5 tests/kit, 25 tests/kit
This product is used for the qualitative detection of 2019-nCoV antigen, Influenza A virus antigen and Influenza B virus antigen in clinical samples.
[Product Feature]
• 1 Sample, 3 targets
• Non-invasive
• Simple to use
• Convenient, no devices required
• Rapid, get result in 15 minutes
• Stable, with high accuracy
Request a Quote >The SARS-CoV-2 Antigen Rapid Test Cassette is a rapid, lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens from nasal swabs and nasopharyngeal swabs. Intended for use in individuals with symptoms or other epidemiological reasons to suspect a SARS-CoV-2 infection, the cassette is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection collected by professionals.
[Product Feature]
• Non-invasive
• Simple to use
• Convenient, no devices required
• Rapid, get the result in 15-20 minutes
• Stable, with high accuracy
• Inexpensive, cost-efficiency
[Principle]The current test cassette is based on a specific antibody-antigen reaction and immunoassay technique.
SARS-CoV-2 Nucleic Acid Test Kit is a real-time PCR test intended for the qualitative detection in ORF1ab and N genes of SARS-CoV-2 viral nucleic acids in pharyngeal specimens (oropharyngeal swabs, nasopharyngeal swabs) from individuals who are suspected of COVID-19 by their healthcare provider.
[Product Features]
• Fast, 2 minutes manually, results within 88 minutes
• Limit of Detection: 100 copies/25μ
• Specificity: 100%
[Packing Size] 24 tests/kit
The test is based on the principle of antigen-antibody reaction and immunoassay technique for the qualitative detection of antibody content against SARS-CoV-2 in clinical samples (serum/plasma/whole blood).
[Product Features]
•Accurate: High-purity antibody with high accuracy
•Efficient: Test result is available in 15mins
•Convenient: Suitable for finger blood
[Packing Size] 20 tests/kit
2019-nCoV Neutralization Antibody Test Kit(Fluorescence Immunochromatography)adopts Fluorescence Immunochromatography technology to detect the neutralizing antibodies in clinical samples for vaccine effect evaluation with rapid and accurate results.
[Product Features]
•Accurate
•Reliable
•Efficient
•Convenient
[Principle] The test kit contains fluorescently-labeled 2019-nCoV Spike Protein (RBD), ACE2 Protein immobilized in test area (T) and the corresponding antibody in quality control area (C).
[Packing Size] 20 tests/kit
2019-nCoV Neutralization Antibody Test kit (Colloidal Gold Immunochromatography) is used to qualitatively detect the 2019-nCoV neutralization antibodies in clinical samples (serum/plasma/whole blood).
[Product Features]
• Accurate
• Reliable
• Efficient
•Convenient
[Principle] The test kit contains colloidal gold labeled 2019-nCoV Spike Protein (RBD), mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area.
[Packing Size] 20 tests/kit
The 2019-nCoV Neutralization Antibody Test Kit (ELISA) is designed to measure the concentration of neutralizing antibodies to COVID-19.It is used for detection of Neutralization Antibodies. Used for qualitative detection of neutralizing antibodies to 2019-nCoV in clinical samples (serum/plasma/ whole blood).
[Product Features]
• High sensitivity (98.61%)
• High specificity (99.11%)
• Rapid results
[Principle] Enzyme-linked Immunosorbent Assay.
[Packing Size] 96 tests/kit
2019-nCoV Neutralization Antibody 2nd Gen Rapid Test Kit (Colloidal Gold Immunochromatography) is used for the qualitative detection of neutralizing antibodies to 2019-nCoV in clinical samples (serum/plasma/whole blood).
[Product Features]
• Accurate
• Reliable
• Efficient
•Convenient
[Principle] The test kit contains colloidal gold-labeled 2019-nCoV Spike Protein (RBD), ACE2 Protein (Human, Recombinant) immobilized in T test area, and the corresponding antibody in the quality control area (C).
[Packing Size] 20 tests/kit
Lepu Medical Technology ( Beijing ) Co., Ltd was established in 1999. It is specialized in developing, manufacturing and marketing high-tech medical devices and equipment.
Today, Lepu Medical has grown into a global leading medical technology company in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, in vitro diagnostic equipment and biomarkers, DSA systems and surgical staplers. In 2009 Lepu Medical successfully went public, and was listed on Chinext Shenzhen StockExchange Market ( stock code: 300003).
Sales channels cover 120+ countries and regions
Obtained local registration in 40+ countries
Established 3 overseas group members located in US, Netherlands, Turkey and India
Have more than 20+ global OEM partners
Now 234 products have received CE certificate
Now 34 products have got FDA approval